Clearance after vasectomy with a single semen sample containing < than 100 000 immotile sperm/mL: analysis of 1073 patients
Ruben A. Korthorst, Dimitri Consten, J. H. van Roijen
Abstract
Ruben A. Korthorst, Dimitri Consten, J. H. van Roijen
Abstract
OBJECTIVE: To evaluate the safety and efficacy of a new semen analysis protocol after vasectomy, where clearance is given to patients who provide a single semen sample with <100 000 immotile sperm/mL at > or = 3 months after vasectomy. PATIENTS AND METHODS: Between 1 July 2005 and 31 March 2008, 1073 men provided a first semen sample at > or = 3 months after vasectomy. Semen was first evaluated on a wet-slide preparation. Those samples with no ('azoospermia') or sporadic immotile spermatozoa could be cleared without further analysis. Samples with motile sperm were immediately labelled as potentially fertile, while those with a significant number of immotile sperm were re-analysed using a Neubauer haemocytometer. All samples with <100 000 immotile sperm/mL were cleared. RESULTS: Of men providing semen at 3 months after vasectomy, 96% could be cleared. No sperm were seen ('azoospermia') in 51.3% of samples, and 44.7% of samples contained <100 000 immotile sperm. No paternity has been reported in the cleared group after a follow-up of at least 1 year. CONCLUSIONS: A protocol stipulating that patients can be cleared after a single semen sample containing <100 000 immotile sperm/mL at > or = 3 months after vasectomy is safe and dramatically reduces the number of men who cannot be cleared at 3 months after vasectomy.
OpenAlex reports 40 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To evaluate the safety and efficacy of a new semen analysis protocol after vasectomy, where clearance is given to patients who provide a single semen sample with <100 000 immotile sperm/mL at > or = 3 months after vasectomy. PATIENTS AND METHODS: Between 1 July 2005 and 31 March 2008, 1073 men provided a first semen sample at > or = 3 months after vasectomy. Semen was first evaluated on a wet-slide preparation. Those samples with no ('azoospermia') or sporadic immotile spermatozoa could be cleared without further analysis. Samples with motile sperm were immediately labelled as potentially fertile, while those with a significant number of immotile sperm were re-analysed using a Neubauer haemocytometer. All samples with <100 000 immotile sperm/mL were cleared. RESULTS: Of men providing semen at 3 months after vasectomy, 96% could be cleared. No sperm were seen ('azoospermia') in 51.3% of samples, and 44.7% of samples contained <100 000 immotile sperm. No paternity has been reported in the cleared group after a follow-up of at least 1 year. CONCLUSIONS: A protocol stipulating that patients can be cleared after a single semen sample containing <100 000 immotile sperm/mL at > or = 3 months after vasectomy is safe and dramatically reduces the number of men who cannot be cleared at 3 months after vasectomy.
Key concepts: Vasectomy, Sperm, Semen, Azoospermia, Clearance, Semen analysis, Andrology, Medicine